Event Type
Disclosure
Mandatory
Variant
8-K
. Results of Operations and Financial Condition. Third Quarter Financial Results On February 26, 2026, Novavax, Inc. (the “Company”) issued a press release anno
. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release, dated Febr uary 26, 2026 , regarding the Company’s financial resu